What Is Bipolar Disorder? Types, Symptoms, Causes, and Treatment
A clinical overview of bipolar disorder — the different types, how manic and depressive episodes present, known causes and risk factors, diagnostic criteria, treatment options, and prevalence data.
This article is for educational purposes only. If you or someone you know is experiencing symptoms of bipolar disorder, consult a qualified mental health professional. In a crisis, contact the 988 Suicide and Crisis Lifeline (call or text 988 in the U.S.).
Definition
Bipolar disorder is a chronic psychiatric condition characterized by recurrent episodes of abnormally elevated mood (mania or hypomania) and episodes of depression. These mood episodes represent significant departures from a person's baseline functioning and are not simply normal fluctuations in mood. The condition was historically known as manic-depressive illness, a term first used by German psychiatrist Emil Kraepelin in the late 19th century.
According to the World Health Organization, bipolar disorder affects approximately 40 million people worldwide. The National Institute of Mental Health (NIMH) estimates that 2.8% of U.S. adults experienced bipolar disorder in the past year, with 4.4% experiencing it at some point in their lifetime. The condition affects men and women at roughly equal rates and typically first appears between ages 15 and 25.
Types of Bipolar Disorder
| Type | Manic Episodes | Depressive Episodes | Key Distinction |
|---|---|---|---|
| Bipolar I | Full manic episodes (≥7 days or requiring hospitalization) | Common but not required for diagnosis | At least one manic episode |
| Bipolar II | Hypomanic episodes only (≥4 days, less severe) | Required — at least one major depressive episode | No full manic episodes; hypomania + depression |
| Cyclothymic Disorder | Hypomanic symptoms (do not meet full criteria) | Depressive symptoms (do not meet full criteria) | Chronic fluctuating mood for ≥2 years |
Bipolar II is not a milder form of Bipolar I — the depressive episodes in Bipolar II are often more frequent, longer-lasting, and more debilitating. People with Bipolar II spend significantly more time in depressive states than those with Bipolar I, according to data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Symptoms: Mania vs. Depression
| Feature | Manic Episode | Depressive Episode |
|---|---|---|
| Mood | Euphoric, expansive, or irritable | Persistent sadness, emptiness, or hopelessness |
| Energy | Markedly increased; decreased need for sleep (e.g., feeling rested after 3 hours) | Fatigue, low energy, difficulty getting out of bed |
| Speech | Rapid, pressured, difficult to interrupt | Slow, quiet, or minimal |
| Thought pattern | Racing thoughts, flight of ideas | Difficulty concentrating, indecisiveness |
| Self-image | Inflated self-esteem, grandiosity | Worthlessness, excessive guilt |
| Behavior | Risky activities: spending sprees, reckless driving, impulsive sexual behavior | Social withdrawal, loss of interest in activities |
| Sleep | Significantly reduced sleep without fatigue | Insomnia or excessive sleeping (hypersomnia) |
| Appetite | Often decreased (too busy/energized to eat) | Significant changes — either loss of appetite or overeating |
| Suicidality | Risk increases in mixed episodes | Significant risk — up to 20x higher than general population |
Hypomania involves the same symptom categories as mania but at reduced severity. Hypomanic episodes do not cause psychotic features (hallucinations, delusions) and do not require hospitalization, though they are clearly observable by others and represent a change from typical behavior.
Causes and Risk Factors
The exact cause of bipolar disorder is not fully understood, but research points to a combination of factors:
- Genetics: Bipolar disorder is one of the most heritable psychiatric conditions. First-degree relatives of someone with bipolar disorder have a 5–10% risk of developing the condition, compared to roughly 2–3% in the general population. Twin studies show concordance rates of 40–70% in identical twins.
- Brain structure and function: Neuroimaging studies have identified differences in the prefrontal cortex and amygdala of individuals with bipolar disorder. Functional MRI research shows altered patterns of activity in brain circuits regulating emotion.
- Neurotransmitters: Dysregulation of dopamine, serotonin, and norepinephrine systems plays a role. Manic episodes are associated with elevated dopamine activity, while depressive episodes correlate with reduced serotonin and norepinephrine signaling.
- Environmental triggers: Stressful life events, sleep disruption, substance use, and seasonal changes can trigger mood episodes in genetically predisposed individuals. Childhood trauma increases risk.
Diagnosis
Bipolar disorder is diagnosed through clinical evaluation based on the criteria in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), published by the American Psychiatric Association. There is no blood test or brain scan that can confirm the diagnosis. Clinicians assess mood history, symptom duration, functional impairment, and rule out other conditions that mimic bipolar symptoms — including thyroid disorders, substance use, and other psychiatric conditions.
Misdiagnosis is common. A 2005 survey by the Depression and Bipolar Support Alliance found that 69% of people with bipolar disorder were initially misdiagnosed, most frequently with unipolar depression. On average, patients waited 10 years from symptom onset to receiving an accurate bipolar diagnosis. This delay occurs partly because patients typically seek help during depressive episodes rather than during mania or hypomania, which they may not recognize as pathological.
Treatment
Medication
Pharmacotherapy is the cornerstone of bipolar disorder management:
- Mood stabilizers: Lithium remains the gold-standard mood stabilizer, with over 60 years of clinical evidence supporting its efficacy in reducing both manic and depressive episodes and lowering suicide risk. Valproate (Depakote) and lamotrigine (Lamictal) are also widely used — lamotrigine is particularly effective for preventing depressive episodes.
- Atypical antipsychotics: Quetiapine (Seroquel), olanzapine (Zyprexa), aripiprazole (Abilify), and lurasidone (Latuda) are FDA-approved for various phases of bipolar disorder treatment.
- Antidepressants: Used cautiously and almost always in combination with a mood stabilizer, as antidepressants alone can trigger manic episodes in bipolar patients — a phenomenon called antidepressant-induced mania.
Psychotherapy
Several forms of therapy have demonstrated effectiveness as adjuncts to medication:
- Cognitive behavioral therapy (CBT): Helps identify and modify thought patterns that contribute to mood episodes.
- Interpersonal and social rhythm therapy (IPSRT): Focuses on stabilizing daily routines — particularly sleep-wake cycles — which are closely linked to mood stability in bipolar disorder.
- Family-focused therapy: Involves family members in treatment, improving communication and reducing relapse rates.
- Psychoeducation: Teaching patients and families about the condition, early warning signs of episodes, and adherence strategies. Studies show psychoeducation alone significantly reduces relapse rates.
Living with Bipolar Disorder
Bipolar disorder is a lifelong condition, but with appropriate treatment, most people achieve significant symptom control. Key factors associated with better outcomes include:
- Consistent medication adherence (treatment discontinuation is the most common cause of relapse)
- Regular sleep patterns — sleep disruption is both a trigger for and early sign of manic episodes
- Avoiding alcohol and recreational drugs, which can destabilize mood and interfere with medications
- Maintaining a mood journal to track early warning signs
- Building a support network of family, friends, and mental health professionals
The condition carries a significant mortality burden. People with bipolar disorder have a life expectancy approximately 9–20 years shorter than the general population, driven by both elevated suicide rates (the lifetime risk of suicide attempt is estimated at 25–50%) and higher rates of cardiovascular disease, diabetes, and other medical comorbidities. Early diagnosis and sustained treatment are critical for improving these outcomes.